2Matsubara T. K-ras point mutation in cancerous and noncancerous biliary epithelium npatient with pancreaticobiliary maljunction. Cancer, 1996,77:1752
3Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert lecture: the role of the P53 tumou-suppressor gene tumorigenesis. Br J Cancer, 1994,69(3):409
4Teh M, Wee W, Raju GC, et al. An immunogistochemical study of P53 protein in gallbladder and extrahepatic bileduct/ampullary carcinoma. Cancer, 1994,74(5):1542
5Masuhara-S, Kasuya-K, Aoki-T, et al. Relation between K-ras codon 12 mutation and P53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J-Hepatobiliary-Pancreat-Surg, 2000,7(2):198～205
7Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutation in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophrosis. Cancer, 1994,73:2727
8Ajiki T, Fujimori H, Onoyama M. K-ras gene mutation in gallbladder carcinoma and dysplsia. Gut, 1996,38:426
9Masakiko Y, Takahiro F, Baisuke A, et al. Expression of oncogenen products and growth factors in early gallbladder cancer, advanced gallbladder cancer and chronic cholecystitis. Hum pathol, 1993,24(4):37
10Lee-CS. Ras P21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma. Eur-J-Surg-Oncol, 1997,23(3):233～237
2Jing-Sen Shi,Jian-Sheng Wang,Gang Liu,Yue-Li Yu,Yun Lu,Xin-Yuan Jiao,Yi-Jun Yang,Guo-Cai Li,Yue Han From the Department of Hopatobiliary Surgery, First Hospital of Xi’an Jiaotong University, Xi’an 710061, China.Early diagnosis of primary gallbladder carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2002,1(2):273-275. 被引量：1
